Generation and Evaluation of a Vaccine Candidate of Attenuated and Heat-resistant Genotype VIII Newcastle Disease Virus

Overview

Journal Poult Sci

Publisher Elsevier

Specialty Veterinary Medicine

Date 2020 Jul 4

PMID 32616237

Citations 6

Authors

Baoyang Ruan

Qian Liu

Yin Chen

Xiaosai Niu

Xuefeng Wang

Chengcheng Zhang

Mengjiao Guo

Xiaorong Zhang

Yongzhong Cao

Yantao Wu

Affiliations

Soon will be listed here.

Abstract

Newcastle disease, which is a highly contagious and fatal disease caused by the Newcastle disease virus (NDV), has harmed the poultry industry for decades. The administration of effective vaccines can control most outbreaks and epidemics of Newcastle disease in the world. However, vaccination failures of live attenuated vaccines becasue of storage and transportation problems have been reported. Hence, thermostable live vaccine strains, such as V4 and I-2 strains, are being used and welcomed in tropical regions such as Africa and Southeast Asia. In this study, a thermostable, attenuated vaccine candidate strain NDV/rHR09 was generated using the genotype VIII heat-resistant virulent NDV strain HR09 by the reverse genetics system. The results of the determination of the mean death time and intracerebral pathogenicity index indicated that NDV/rHR09 is lentogenic even after 15 serial passages in embryonated chicken eggs. The thermostability assessment showed that the NDV/rHR09 strain exhibited hemagglutination activity and infectivity when exposed to 56°C for 60 min. Compared with the commercially available La Sota and V4 vaccines, the NDV/rHR09 induced higher antibody titers in specific pathogen-free chickens. In addition, NDV/rHR09 conferred complete protection against virulent genotype VII NDV challenge and virus shedding from vaccinated chickens. These results suggest that NDV/rHR09 is a promising thermostable vaccine candidate strain.

Citing Articles

Newcastle Disease Vaccination Program in Broilers Using an Apathogenic Heat-Resistant Vaccine.

Ghafouri S, Ghaniei A, Moghani M, Lotfalizadeh N Arch Razi Inst. 2024; 79(3):541-548.

PMID: 39736953 PMC: 11682497. DOI: 10.32592/ARI.2024.79.3.541.

Construction of Novel Thermostable Chimeric Vaccine Candidates for Genotype VII Newcastle Disease Virus.

Cao Y, Bo Z, Ruan B, Guo M, Zhang C, Zhang X Viruses. 2023; 15(1).

PMID: 36680122 PMC: 9866313. DOI: 10.3390/v15010082.

Current situation and future direction of Newcastle disease vaccines.

Hu Z, He X, Deng J, Hu J, Liu X Vet Res. 2022; 53(1):99.

PMID: 36435802 PMC: 9701384. DOI: 10.1186/s13567-022-01118-w.

Thermostable Vaccines in Veterinary Medicine: State of the Art and Opportunities to Be Seized.

Fanelli A, Mantegazza L, Hendrickx S, Capua I Vaccines (Basel). 2022; 10(2).

PMID: 35214703 PMC: 8876287. DOI: 10.3390/vaccines10020245.

Generation and Evaluation of Recombinant Thermostable Newcastle Disease Virus Expressing the HA of H9N2 Avian Influenza Virus.

Zhang X, Bo Z, Meng C, Chen Y, Zhang C, Cao Y Viruses. 2021; 13(8).

PMID: 34452473 PMC: 8402907. DOI: 10.3390/v13081606.

References

Chumbe A, Izquierdo-Lara R, Calderon K, Fernandez-Diaz M, Vakharia V . Development of a novel Newcastle disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein. Virol J. 2017; 14(1):232. PMC: 5701357. DOI: 10.1186/s12985-017-0900-8. View

Hu Z, Hu S, Meng C, Wang X, Zhu J, Liu X . Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs. Avian Dis. 2011; 55(3):391-7. DOI: 10.1637/9633-122410-Reg.1. View

Foster H, Chitukuro H, Tuppa E, Mwanjala T, Kusila C . Thermostable Newcastle disease vaccines in Tanzania. Vet Microbiol. 1999; 68(1-2):127-30. DOI: 10.1016/s0378-1135(99)00068-1. View

Romer-Oberdorfer A, Werner O, Veits J, Mebatsion T, Mettenleiter T . Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity. J Gen Virol. 2003; 84(Pt 11):3121-3129. DOI: 10.1099/vir.0.19416-0. View

Alexander D . Newcastle disease and other avian paramyxoviruses. Rev Sci Tech. 2000; 19(2):443-62. DOI: 10.20506/rst.19.2.1231. View

Peeters B, de Leeuw O, Koch G, Gielkens A . Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J Virol. 1999; 73(6):5001-9. PMC: 112544. DOI: 10.1128/JVI.73.6.5001-5009.1999. View

Bensink Z, Spradbrow P . Newcastle disease virus strain I2--a prospective thermostable vaccine for use in developing countries. Vet Microbiol. 1999; 68(1-2):131-9. DOI: 10.1016/s0378-1135(99)00069-3. View

Cao Y, Liu Q, Zhang X, Hu H, Wu Y . Complete Genome Sequence of Heat-Resistant Newcastle Disease Virus Strain HR09. Genome Announc. 2017; 5(44). PMC: 5668531. DOI: 10.1128/genomeA.01149-17. View

Xu D, Li C, Liu G, Chen Z, Jia R . Generation and evaluation of a recombinant goose origin Newcastle disease virus expressing Cap protein of goose origin avastrovirus as a bivalent vaccine in goslings. Poult Sci. 2019; 98(10):4426-4432. DOI: 10.3382/ps/pez255. View

10.

Wen G, Hu X, Zhao K, Wang H, Zhang Z, Zhang T . Molecular basis for the thermostability of Newcastle disease virus. Sci Rep. 2016; 6:22492. PMC: 4776148. DOI: 10.1038/srep22492. View

11.

Johnson K, Zeddam J, Ball L . Characterization and construction of functional cDNA clones of Pariacoto virus, the first Alphanodavirus isolated outside Australasia. J Virol. 2000; 74(11):5123-32. PMC: 110865. DOI: 10.1128/jvi.74.11.5123-5132.2000. View

12.

Dimitrov K, Afonso C, Yu Q, Miller P . Newcastle disease vaccines-A solved problem or a continuous challenge?. Vet Microbiol. 2016; 206:126-136. PMC: 7131810. DOI: 10.1016/j.vetmic.2016.12.019. View

13.

Panda A, Huang Z, Elankumaran S, Rockemann D, Samal S . Role of fusion protein cleavage site in the virulence of Newcastle disease virus. Microb Pathog. 2003; 36(1):1-10. PMC: 7125746. DOI: 10.1016/j.micpath.2003.07.003. View

14.

Wei T, Deng Q, Zhai G, He C, Li H, Zhang Y . Re-emergence of a genotype VIII virulent Newcastle disease virus isolated from Chinese game fowl after 13 years. Transbound Emerg Dis. 2019; 66(2):1077-1084. DOI: 10.1111/tbed.13129. View

15.

Farkas T, Szekely E, Belak S, Kiss I . Real-time PCR-based pathotyping of Newcastle disease virus by use of TaqMan minor groove binder probes. J Clin Microbiol. 2009; 47(7):2114-23. PMC: 2708511. DOI: 10.1128/JCM.01652-08. View

16.

Yadav K, Pathak D, Saikia D, Debnath A, Ramakrishnan S, Dey S . Generation and evaluation of a recombinant Newcastle disease virus strain R2B with an altered fusion protein cleavage site as a vaccine candidate. Microb Pathog. 2018; 118:230-237. DOI: 10.1016/j.micpath.2018.03.038. View

17.

Tan L, Xu H, Wang Y, Qin Z, Sun L, Liu W . Molecular characterization of three new virulent Newcastle disease virus variants isolated in China. J Clin Microbiol. 2007; 46(2):750-3. PMC: 2238101. DOI: 10.1128/JCM.01587-07. View

18.

Susta L, Jones M, Cattoli G, Cardenas-Garcia S, Miller P, Brown C . Pathologic characterization of genotypes XIV and XVII Newcastle disease viruses and efficacy of classical vaccination on specific pathogen-free birds. Vet Pathol. 2014; 52(1):120-31. DOI: 10.1177/0300985814521247. View

19.

Kapczynski D, King D . Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic.... Vaccine. 2005; 23(26):3424-33. DOI: 10.1016/j.vaccine.2005.01.140. View

20.

Alders R . Making Newcastle disease vaccines available at village level. Vet Rec. 2014; 174(20):502-3. DOI: 10.1136/vr.g3209. View